EBITDA multiple

 

German prospects in 2024: Twice the bankruptcies, half the investment

Between stark drops in investment, the prospect of mass nursing home bankruptcies, and the German Hospital Association warning insolvencies could double in 2024, Germany’s healthcare market is becoming the sick man of Europe. HBI asks a cohort of market experts how the patient is doing, and whether there is a cure.

Aster DM sells majority stake in Gulf business for $1bn

Dubai-based listed hospital and pharmacy chain Aster DM is selling a majority 65% stake in its Gulf business for a shade over $1bn to a consortium led by PE investor Fajr Capital. HBI investigates the thinking behind the deal, what this means for the group's expansion plans, and looks at the future of the GCC market generally with the help of expert commentary. 

EDG sale predicted for Q1 2024

Multiple sources tell HBI that Nordic Capital-owned multinational European Dental Group (EDG) will be back on the market in Q1 ’24. HBI also hears Mehilainen could be back in the shop window soon too.

Cinven goes ahead with Synlab take-private

UK PE group Cinven is pushing ahead with its €10-per-share acquisition of multinational labs group Synlab by launching a public acquisition offer to all shareholders. This comes after several months of slience after Cinven made an initial non-binding offer to take the group private back in March. 

Blackstone likely buyer of KIMS Health

US private equity firm Blackstone has emerged as the likely buyer in the sale process of KIMS Health, an Indian hospital group which also has multiple hospitals and clinics in the Middle East.

$1.5bn Ramsay Sime Darby for sale (again)

Ramsay Sime Darby, the South East Asian branch of multinational Australian hospital giant Ramsay, is up for sale again. The owners are reportedly seeking a valuation of around $1.5bn, which would make it the largest health care deal in the South East Asian region since 2019.

€1bn+ Luz Saúde IPO could mark return of European health care listings

Luz Saúde, Portugal’s second largest private hospital group by revenue, is set to become a listed company once again after five years of being privately held, in an IPO which could mark the return of European health care listings. The group’s insurer owner Fidelidade plans to retain a strategic majority stake.

Temasek buys $2bn additional stake in Manipal

Singaporean state-owned investment conglomerate Temasek is to become majority shareholder in Manipal Hospitals, one of India’s largest hospital chains, as it increases its stake from 18% to 59%.

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

Find Us